The medical device MOWOOT has been developed and tested by the healthtech company usMIMA in collaboration with doctors and physiotherapists of the neuro-rehabilitation center Institut Guttmann.
Through hundreds of interviews with patients at Institut Guttman, the usMIMA team verified the enormous impact that chronic constipation has on the quality of life of people with spinal cord injuries. usMIMA investigated for months to develop a solution that would avoid the use of laxatives or reduce it to a minimum until they found the key: a new therapy inspired by the abdominal massage that the therapists of the Institut Guttmann administer to their patients to relieve the chronic constipation.
Dr. Eloy Opisso, executive coordinator of Institut Guttmann’s Office of Research and Innovation, explains how MOWOOT was developed.
The founders of usMIMA met in Moebio’s dHEALTH BCN program, a disruptive talent development initiative powered by Biocat and inspired by Stanford Biodesign.
The usMIMA team has developed MOWOOT to improve the quality of life of those affected by constipation. And both, to ensure MOWOOT’s success and to complete the information already available in their clinical trials, they are personally assisting you with advise to resolve your doubts about the product.
Collaborations and recognitions
MOWOOT has been developed with the collaboration of Institut Guttmann, a reference hospital in Europe in the field of neurorehabilitation, its effectiveness has been clinically proven and has received numerous awards and recognitions.
MOWOOT and usMIMA have received multiple awards, certifications and acknowledgments that support the effectiveness of this solution for chronic constipation:
First Prize BioEmprendedorXXI, promoted by La Caixa, BarcelonaActiva, Barcelona City Council and Biocat
First Prize Everis Award, section “Biotechnology and Health”, promoted by Everis Foundation and Everis Group
Recognition as one of the "TOP 10 innovative startups with social impact in Spain" by TEDx Binnenhof / European Commission and ENISA
Quality label "Innovative SME" of MINECO (Ministry of Economy and Competitiveness) (December 2015)
European Commission / Horizon 2020 Seal of Excellence
CE certification as a class IIa medical device, subject to special controls to demonstrate its safety and effectiveness. This certification guarantees that MOWOOT complies with the quality standards of the European Union
14 April, 2019
Dr. Markus Wilhelms, CEO at MOWOOT, talks about the future projects of the company at L’Econòmic weekly newspaper.
20 March, 2019
Marc Benet, co-founder of MOWOOT, appears on the special monograph of the newspaper La Vanguardia: ‘Learn to innovate, innovating’, along ...
19 November, 2018
Robert Calvo interviews (min. 45.20) Dr. Immaculada Herrero, CSO of MOWOOT, at the radio show La Brúixola, Onda Cero Catalunya (...
14 November, 2018
MOWOOT appears in special monograph of the newspaper La Vanguardia: “Smart solutions that impact health”.
The usMIMA team
CEO and co-founder.
Doctor in Molecular Microbiology.
CSO and co-founder.
Doctor in Biological Sciences by the Department of Medicine.
CRMO and co-founder
Master in Engineering of the Design specialized in Industrial Prototyping.
CTO and co-founder.
Doctor in Information and Communication Technologies and its management.
Do you have any doubts?
Leave us your contact information and we advise you.